Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group — D. Skarlos (2003) | RDL Network
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group
Vasilios Karavasilis, P. Kosmidis, Konstantinos N. Syrigos, Polyxeni Mavropoulou, Meletios A Dimopoulos, Vassiliki Kotoula, Dimitrios Pectasides, Ioannis Boukovinas, G. Klouvas, Anna Kalogera‐Fountzila, Christos N. Papandreou, George Fountzilas, Evangelos Briasoulis
D. Pectasides, Gerasimos Aravantinos, Haralabos P. Kalofonos, Christos Kiamouris, D. Bafaloukos, Nikolaos I. Xiros, C. Nicolaides, A. Visvikis, Meletios A Dimopoulos
P. Kosmidis, Haralabos P. Kalofonos, C. Christodoulou, K. Syrigos, Thomas Makatsoris, D. Skarlos, C. Bakogiannis, C. Nicolaides, Dimitrios Bafaloukos, Aristotelis Bamias, E. Samantas, Nikolaos I. Xiros, Ioannis Boukovinas, George Fountzilas, Meletios A Dimopoulos
P. Kosmidis, George Fountzilas, Anastasia G Eleftheraki, Haralabos P. Kalofonos, George Pentheroudakis, Dimosthenis Skarlos, Meletios A Dimopoulos, Dimitrios Bafaloukos, Dimitrios Pectasides, E. Samantas, J. Boukovinas, Sofia Lambaki, N. Katirtzoglou, C. Bakogiannis, Konstantinos N. Syrigos
Discussion(0)
No comments yet. Be the first to comment.